Galecto
Latest round
- Series D
Last raised
- Sep 2020
Total raised
- $164M
Investors
- 21
About Galecto
Galecto, Inc.Galecto, Inc. operates in the biopharmaceutical sector, developing therapies targeting severe diseases. The company was founded in 2011 in Copenhagen, Denmark. Tariq Sethi is the founder of the company.Galecto, Inc. primarily develops innovative small molecules aimed at treating severe diseases, particularly focusing on galectin modulators that target critical disease pathways. Their product line includes galectin-3 inhibitors and ENL-YEATS / FLT3 inhibitors, which provide therapeutic options for patients with acute myeloid leukemia (AML) and severe liver diseases like hepatocellular carcinoma (HCC).Galecto, Inc. generates revenue through strategic partnerships and collaborations for the development and commercialization of its therapeutic candidates. The company engages in B2B agreements, focusing on joint development efforts or licensing agreements with pharmaceutical companies and research institutions. The revenue model involves structured payments tied to clinical milestones, along with potential royalties upon successful product commercialization.Galecto, Inc. The company aims to expand its market presence in Europe and North America, targeting further development of its pipeline by 2023.
Who invested in Galecto
21 investors across 5 rounds
See all investors in Galecto
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Galecto
Who invested in Galecto?
Galecto has 21 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Galecto raised?
Galecto has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Galecto last raise money?
Galecto's most recent round on record is a Series D, in Sep 2020.
What does Galecto do?
Galecto is a pharmaceuticals company.
Where is Galecto headquartered?
Galecto is headquartered in Copenhagen, Denmark.
Which VCs invest in companies like Galecto?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Galecto's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Galecto? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.